Melatonin supplementation counteracts fiber loss in knee ligaments of diabetes-induced rats.

diabetes ligaments diabetes mellitus ligaments alteration ligaments alteration in diabetes mellitus orthopedic complications

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2024
Historique:
received: 12 03 2024
accepted: 24 06 2024
medline: 13 8 2024
pubmed: 13 8 2024
entrez: 13 8 2024
Statut: epublish

Résumé

Diabetes mellitus (DM) is a prevalent metabolic disease. The clinical impact of sustained hyperglycemia on ligament healing has not been well characterized. Diabetes is a known cause of macro-, microvascular, and diabetic ulcer healing difficulties among tissues. Therefore, we aimed to investigate the healing potential occurring in injured and healthy ligaments among diabetic and healthy individuals using a rat model. We hypothesize that DM may contribute to altering the knee medial collateral ligament (MCL), thus its morphology, biochemical fitness, and functionality. The study cohort consisted of 40 rats. The animals were randomized into four equal groups. Groups I and II (20 rats) received saline subcutaneously and served as controls. Groups III and IV (20 rats) were injected with a single dose of streptozotocin (STZ). All animals underwent surgery to cut the left tibial collateral ligament in the hind limb and suture it. The access site was sutured to create inflammation and study the regenerative capacities of animals with normal carbohydrate metabolism and pharmacologically induced diabetes. Each animal then underwent sham surgery to access and suture the right tibial collateral ligament in the hind limb without ligament intervention. After the animals had undergone surgeries, groups II and IV were given melatonin supplementation for 4 weeks. Rats with DM presented with more fibrosis and calcification of the MCL and decreased healing potential. Treatment with melatonin in diabetic rats mitigated alterations and improved the antioxidant status of ligaments from the diabetic group.

Identifiants

pubmed: 39135805
doi: 10.3389/fphar.2024.1399719
pii: 1399719
pmc: PMC11317382
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1399719

Informations de copyright

Copyright © 2024 Adamska, Wnuk, Kamińska, Poniatowska, Maciąg, Kamiński, Stolarczyk, Matin, Atanasov, Łapiński and Jóźwik.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Olga Adamska (O)

Department of Ophthalmology, Collegium Medicum, Cardinal Stefan Wyszynski University, Warsaw, Poland.

Artur Wnuk (A)

Hospital in Ostrow Mazowiecka, Ostrów Mazowiecka, Poland.

Agnieszka Kamińska (A)

Department of Ophthalmology, Collegium Medicum, Cardinal Stefan Wyszynski University, Warsaw, Poland.

Małgorzata Poniatowska (M)

Department of Nuclear Medicine, Pomeranian Medical University in Szczecin, Szczecin, Poland.

Bartosz Maciąg (B)

Orthopedic and Rehabilitation Department, Medical University of Warsaw, Warsaw, Poland.

Maciej Kamiński (M)

Medical Faculty, Lazarski University, Warsaw, Poland.

Artur Stolarczyk (A)

Orthopedic and Rehabilitation Department, Medical University of Warsaw, Warsaw, Poland.

Maima Matin (M)

Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, Magdalenka, Poland.

Atanas G Atanasov (AG)

Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, Magdalenka, Poland.
Laboratory of Natural Products and Medicinal Chemistry (LNPMC), Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, India.
Ludwig Boltzmann Institute Digital Health and Patient Safety, Medical University of Vienna, Vienna, Austria.

Marcin Łapiński (M)

Orthopedic and Rehabilitation Department, Medical University of Warsaw, Warsaw, Poland.

Artur Jóźwik (A)

Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, Magdalenka, Poland.

Classifications MeSH